The independent-practice coalition Strategic Radiology has founded a captive health insurance program to offer its 1,500 or so member physicians and their respective support staffs.  

A med-tech leader of note is taking skills refined at Amazon, the FDA and the CDC to GE HealthCare, where he will serve as the newly independent company’s first CTO. 

GE HealthCare has begun trading as an independent company on the Nasdaq exchange. To mark the occasion and showcase its completed spinoff from General Electric, the company remotely rang the opening bell at Nasdaq from its manufacturing facility in Waukesha, Wis.

A published list shows all three grossing an annual salary of at least $1.95 million in Canadian Medicare billings.

The FDA has cleared Polarean Imaging’s xenon gas-based MRI contrast agent for evaluating pulmonary function in patients aged 12 years and up.

Noteworthy market developments listed in the order announcements were posted.   

Healthcare stakeholders throughout U.S. medicine, including radiology leaders, aren’t waiting for the ink to dry before speaking their minds.

A molecular contrast agent previously cleared for use during surgery for ovarian cancer may now be used in similar fashion during lung operations.